Research Topics
| Catherine S C BoumanSummaryAffiliation: Academic Medical Center Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapyAnnick A N M Royakkers
Department of Anesthesiology, Tergooi Hospitals, location Blaricum, Blaricum, The Netherlands
Intensive Care Med 37:493-501. 2011....
Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltrationCatherine S C Bouman
Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Curr Opin Crit Care 14:654-9. 2008..The present contribution discusses the principles of drug dosing during CVVH and compares the various proposed dosing strategies...
Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosingCatherine S C Bouman
Department of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Intensive Care Med 32:2013-9. 2006..We compared the observed Cl(CVVH) (SC x Q(uf)) with the estimated Cl(CVVH) (estimated F(UP) x Q(uf)) and determined the effect on the maintenance dose multiplication factor (MDMF)...
The effects of continuous venovenous hemofiltration on coagulation activationCatherine S C Bouman
Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands
Crit Care 10:R150. 2006..In contrast to previous studies, CVVH was performed without anticoagulation...
Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timingCatherine S C Bouman
Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands
J Crit Care 22:1-12. 2007..The aim of this review was to determine the importance of ultrafiltration dose and timing on the physiologic and clinical effects of HF in sepsis and SIRS. In addition, we discuss the issue of filter pore size...
Timing of renal replacement therapy in critically ill patients with acute kidney injuryCatherine S C Bouman
Academic Medical Center, Department of Intensive Care, University of Amsterdam, Amsterdam, The Netherlands
Curr Opin Crit Care 13:656-61. 2007..Timing of renal replacement therapy in critically ill patients with acute kidney injury is highly subjective, and may influence outcome. We discuss renal and nonrenal criteria for timing considering the recent literature...
Serum cystatin C-A useful endogenous marker of renal function in intensive care unit patients at risk for or with acute renal failure?Annick A N M Royakkers
Department of Intensive Care, Tergooi Hospitals, location Blaricum, Rijksstraatweg 1, 1261 AN Blaricum, The Netherlands
Curr Med Chem 14:2314-7. 2007..Cystatin C could be an important tool both to recognize early renal dysfunction and to identify renal recovery while on CRRT in the critically ill patient, however, we are in need of more studies...
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trialCatherine S C Bouman
Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands
Crit Care Med 30:2205-11. 2002..CONCLUSIONS: In the present study of critically ill patients with oliguric acute renal failure, survival at 28 days and recovery of renal function were not improved using high ultrafiltrate volumes or early initiation of hemofiltration...
Cystatin C in critically ill patients treated with continuous venovenous hemofiltrationMarije C Baas
Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Hemodial Int 10:S33-7. 2006..Therefore, CVVH (2 L/hr) is unlikely to influence serum concentrations of CysC significantly, which suggests that it can be used to monitor residual renal function during CVVH...
Cooling the crisis: therapeutic hypothermia after sickle cardiac arrestHennie A Metske
Departments of Intensive Care, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Crit Care Med 40:651-3. 2012..Rigorous exchange transfusion may enable mild therapeutic hypothermia after cardiac arrest in patients with sickle-cell disease...
Of hypes and hopes: N-acetylcysteine and cystatin CMarcus J Schultz
AJR Am J Roentgenol 190:W224; author reply W225. 2008
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi processJohn A Kellum
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Scaife Hall, Room 608, 3550 Terrace Street, Pittsburgh, PA 15261, USA
Clin J Am Soc Nephrol 3:887-94. 2008..An international, consensus-based, prioritized research agenda was sought to guide clinical and translational research in acute kidney injury...
